Current Concepts in Scaffolds and Growth Factors for Meniscal Repair

High-Yield Summary

• Meniscal repair success depends on vascularity; scaffolds and growth factors aim to enhance healing in avascular zones.
• Biologic augmentation with scaffolds (e.g., collagen, synthetic polymers) provides a matrix for cell infiltration and tissue regeneration.
• Growth factors such as platelet-rich plasma (PRP) and bone morphogenetic proteins (BMPs) modulate cellular proliferation and extracellular matrix synthesis.
• Patient selection, tear patternand concomitant pathology dictate the choice and timing of scaffold and growth factor use.
• Current evidence supports combined scaffold and growth factor strategies to improve repair rates, but standardized protocols remain under development.

Clinical Fundamentals

The meniscus is a fibrocartilaginous structure critical for load transmission, shock absorptionand joint stability. It consists primarily of type I collagen arranged circumferentially, with radial tie fibers providing structural integrity. The peripheral 10-30% of the meniscus is vascularized (red-red and red-white zones), whereas the inner two-thirds (white-white zone) are avascular, limiting intrinsic healing capacity.

Biomechanically, the meniscus converts axial loads into hoop stresses, protecting articular cartilage. Meniscal tears disrupt this function, accelerating osteoarthritis if untreated or improperly managed. Epidemiologically, meniscal injuries are common in young athletes and older patients with degenerative changes, with repair favored in younger, active patients and tears in vascular zones.

Classification & Diagnosis

Decision-Making Algorithm

Non-operative management is reserved for small, stable tears in avascular zones without mechanical symptoms or in low-demand patients. Operative repair is indicated for:

• Tears in vascular zones (red-red, red-white) with good tissue quality
• Longitudinal vertical tears, especially in younger patients
• Root tears and displaced bucket-handle tears causing mechanical symptoms

Scaffold and growth factor augmentation is considered when:

• Tear is in avascular or borderline vascular zones
• Tissue quality is poor or chronicity reduces healing potential
• Concomitant procedures (e.g., ACL reconstruction) provide a biologic milieu enhancing repair

Surgical approach selection depends on tear location and pattern. Inside-out and all-inside repair devices are standard; scaffolds are implanted arthroscopically or via mini-open approaches. Growth factors are delivered via PRP injections or incorporated into scaffolds.

Surgical Mastery & Pearls

1. Preparation: Debride tear edges to stable, bleeding tissue; avoid excessive meniscal excision.
2. Scaffold Placement: Select scaffold material based on tear size and location-collagen-based scaffolds for partial defects, synthetic polymers for larger or complex tears. Secure scaffold with sutures or fibrin glue, ensuring intimate contact with native meniscus and vascular bed.
3. Growth Factor Application: Apply PRP or BMPs directly to repair site or impregnate scaffold pre-implantation. Timing is critical-apply after mechanical fixation to prevent washout.
4. Suture Technique: Use vertical mattress sutures for circumferential stability; ensure knots are tied securely but avoid overtensioning to prevent tissue strangulation.
5. Intraoperative Red Flags: Poor tissue quality, excessive meniscal extrusionor inability to achieve stable fixation predict repair failure; consider augmentation or partial meniscectomy.
6. Postoperative Protocol: Protect repair with restricted weight-bearing and limited knee flexion initially; gradual rehabilitation to restore range of motion and strength.

Evidence-Based Synthesis

Landmark randomized controlled trials have demonstrated improved healing rates with biologic augmentation compared to repair alone, particularly in avascular zones. Studies comparing collagen scaffolds to synthetic alternatives show comparable integration but variable resorption profiles. PRP augmentation yields mixed results; some trials report enhanced vascularity and cellular proliferation, while others show no significant clinical benefit, reflecting heterogeneity in preparation and application protocols.

Recent meta-analyses underscore the importance of combined scaffold and growth factor use, especially in chronic or complex tears, but highlight the lack of standardized dosing and delivery methods. Emerging data suggest that scaffold porosity and growth factor release kinetics critically influence outcomes, prompting ongoing biomaterial innovation.

Clinical consensus favors individualized treatment plans integrating patient factors, tear characteristicsand biologic adjuncts. However, high-level evidence remains limitedand further multicenter trials are needed to define optimal scaffold compositions and growth factor regimens.

Master Class Pro-Tip

Mastery in meniscal repair with scaffolds and growth factors hinges on tailoring the biologic environment to the mechanical demands of the tear. Prioritize meticulous preparation of the vascular bed and precise scaffold fixation to maximize cellular ingress. Employ growth factors not as a universal remedy but as a targeted tool-optimize timing, concentrationand delivery vehicle to synergize with the scaffold’s architecture. Recognize that surgical finesse in tensioning sutures and preserving meniscal contour directly influences scaffold integration and long-term joint preservation.

Last Updated on September 18, 2026 by OrthoNet AI